Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 11Recruiting 4Unknown 1Terminated 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 12Head & Neck 12Tumor-Agnostic 9Gynecologic 8Genitourinary 8Gastrointestinal 7Dermatologic 6Sarcoma 4CNS 3Other solid neoplasm 2Plasma cell 1NET 1Myeloid 1Endocrine 1

Conditions

Neuroendocrine Tumors 52Gastro-enteropancreatic neuroendocrine tumor 10Carcinoma, Neuroendocrine 8Small Cell Lung Carcinoma 6Adenoma, Islet Cell 6Colorectal Neoplasms 5Carcinoma, Merkel Cell 4Pancreatic Neoplasms 3Cholangiocarcinoma 3Carcinoma, Hepatocellular 3Carcinoid Tumor 3Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Stomach Neoplasms 2Sarcoma 2Salivary Gland Neoplasms 2Pheochromocytoma 2Paraganglioma 2Neoplasms, Unknown Primary 2Neoplasms 2Microsatellite Instability 2Mesothelioma 2Lung Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Medullary 2Brain Neoplasms 2Biliary Tract Neoplasms 2Vulvar Neoplasms 1Vipoma 1Urinary Bladder Neoplasms 1

Interventions

lutetium Lu 177 dotatate 1avelumab 1Radiotherapy 1Lutetium-177 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Carcinoma × NET × Clear all
NCT04261855 2026-03-27

GoTHAM

Melanoma and Skin Cancer Trials Limited

Phase 1/2 Active not recruiting
19 enrolled
DermatologicEndocrineNET

Carcinoma, Carcinoma, Merkel Cell, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡